Enzimas Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Enzimas General Information

Description

Manufacturer of various types of enzymes. The company offers Trypsin and Chymotrypsin enzymes which are extracted from bovine and porcine glands.

Contact Information

Website
www.enzimas.com.ar
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • San Rafael 1950
  • Lujan, 6700
  • Argentina
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Atrium Innovations
Vertical(s)
Manufacturing
Corporate Office
  • San Rafael 1950
  • Lujan, 6700
  • Argentina

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzimas Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enzimas‘s full profile, request access.

Request a free trial

Enzimas Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzimas FAQs

  • When was Enzimas founded?

    Enzimas was founded in 1993.

  • Where is Enzimas headquartered?

    Enzimas is headquartered in Lujan, Argentina.

  • What is the size of Enzimas?

    Enzimas has 50 total employees.

  • What industry is Enzimas in?

    Enzimas’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Enzimas a private or public company?

    Enzimas is a Private company.

  • What is Enzimas’s current revenue?

    The current revenue for Enzimas is .

  • When was Enzimas acquired?

    Enzimas was acquired on 18-Aug-2011.

  • Who acquired Enzimas?

    Enzimas was acquired by Atrium Innovations.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process